Suchergebnisse - "Burmester, Gerd R"

PubPharm (31)

1

Obexelimab in IgG4-related disease : B-cell inhibition as a novel therapeutic approach

enthalten in: The Lancet. Rheumatology | 2023

von Alexander, T. | Burmester, G.

2

Disease Activity Cutoff Values in Initiating Tumor Necrosis Factor Inhibitor Therapy in Ankylosing Spondylitis : A German GO-NICE Study Subanalysis

enthalten in: The Journal of rheumatology | 2020

von Braun, J. | Baraliakos, X. | Kiltz, U. | +4

3

Patient-reported outcomes with golimumab in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis : non-interventional study GO-NICE in Germany

enthalten in: Rheumatology international | 2019

von Krüger, K. | Burmester, G. | Wassenberg, S. | +2

4

Effectiveness and safety of golimumab in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis under real-life clinical conditions : non-interventional GO-NICE study in Germany

enthalten in: BMJ open | 2018

von Krüger, K. | Burmester, G. | Wassenberg, S. | +2

5

Mavrilimumab, a Fully Human Granulocyte-Macrophage Colony-Stimulating Factor Receptor α Monoclonal Antibody : Long-Term Safety and Efficacy in Patients With Rheumatoid Arthritis

enthalten in: Arthritis & rheumatology (Hoboken, N.J.) | 2018

von Burmester, G. | McInnes, I. | Kremer, J. | +8

6

A Randomized Phase IIb Study of Mavrilimumab and Golimumab in Rheumatoid Arthritis

enthalten in: Arthritis & rheumatology (Hoboken, N.J.) | 2018

von Weinblatt, M. | McInnes, I. | Kremer, J. | +9

7

A randomised phase IIb study of mavrilimumab, a novel GM-CSF receptor alpha monoclonal antibody, in the treatment of rheumatoid arthritis

enthalten in: Annals of the rheumatic diseases | 2017

von Burmester, G. | McInnes, I. | Kremer, J. | +16

8

The changing landscape of biosimilars in rheumatology

enthalten in: Annals of the rheumatic diseases | 2016

von Dörner, T. | Strand, V. | Cornes, P. | +7

9

Association of HLA-DRB1 alleles with clinical responses to the anti-interleukin-17A monoclonal antibody secukinumab in active rheumatoid arthritis

enthalten in: Rheumatology (Oxford, England) | 2016

von Burmester, G. | Durez, P. | Shestakova, G. | +9

10

Efficacy and safety of mavrilimumab in subjects with rheumatoid arthritis

enthalten in: Annals of the rheumatic diseases | 2013

von Burmester, G. | Weinblatt, M. | McInnes, I. | +12